Michel van Agthoven

1.3k total citations
59 papers, 1.0k citations indexed

About

Michel van Agthoven is a scholar working on Economics and Econometrics, Pathology and Forensic Medicine and Otorhinolaryngology. According to data from OpenAlex, Michel van Agthoven has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 15 papers in Pathology and Forensic Medicine and 13 papers in Otorhinolaryngology. Recurrent topics in Michel van Agthoven's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Head and Neck Cancer Studies (11 papers). Michel van Agthoven is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Head and Neck Cancer Studies (11 papers). Michel van Agthoven collaborates with scholars based in Netherlands, United States and Belgium. Michel van Agthoven's co-authors include Carin A. Uyl‐de Groot, C. René Leemans, Pieter Sonneveld, Bronno van der Holt, Marc Koopmanschap, Jan B. Oostenbrink, Frans Rutten, LF Verdonck, Peter C. Levendag and Johannes A. Langendijk and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Michel van Agthoven

55 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel van Agthoven Netherlands 18 265 250 202 179 150 59 1.0k
Roger J. Black United Kingdom 17 333 1.3× 56 0.2× 234 1.2× 229 1.3× 220 1.5× 31 1.1k
Andreas Krüll Germany 19 390 1.5× 190 0.8× 251 1.2× 59 0.3× 324 2.2× 78 1.1k
Dachao Liu United States 20 676 2.6× 151 0.6× 200 1.0× 77 0.4× 327 2.2× 38 1.5k
Glenn Jones Canada 23 644 2.4× 93 0.4× 236 1.2× 404 2.3× 382 2.5× 69 2.0k
Angelina D. Tan United States 21 395 1.5× 103 0.4× 114 0.6× 48 0.3× 606 4.0× 49 1.5k
James A. Lipsett United States 19 603 2.3× 80 0.3× 432 2.1× 181 1.0× 232 1.5× 29 1.3k
Elizabeth Brown Australia 15 238 0.9× 161 0.6× 129 0.6× 30 0.2× 248 1.7× 48 1.1k
Patrick D. Maguire United States 14 498 1.9× 115 0.5× 214 1.1× 93 0.5× 439 2.9× 31 1.2k
Powell L. Graham United States 9 608 2.3× 68 0.3× 205 1.0× 74 0.4× 383 2.6× 11 1.2k
T.J. Wilhite United States 7 872 3.3× 71 0.3× 211 1.0× 77 0.4× 432 2.9× 15 1.3k

Countries citing papers authored by Michel van Agthoven

Since Specialization
Citations

This map shows the geographic impact of Michel van Agthoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel van Agthoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel van Agthoven more than expected).

Fields of papers citing papers by Michel van Agthoven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel van Agthoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel van Agthoven. The network helps show where Michel van Agthoven may publish in the future.

Co-authorship network of co-authors of Michel van Agthoven

This figure shows the co-authorship network connecting the top 25 collaborators of Michel van Agthoven. A scholar is included among the top collaborators of Michel van Agthoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel van Agthoven. Michel van Agthoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luyten, Jeroen, et al.. (2025). Measuring Experienced Utility in the Context of Health Economic Evaluation: A Narrative Overview. Health Science Reports. 8(5). e70754–e70754.
2.
Groenland, Edward, et al.. (2023). Rethinking the eidos, genos, and diaphora of the health utility concept: a psychological perspective. Frontiers in Psychology. 14. 1139931–1139931. 2 indexed citations
3.
Groenland, Edward, et al.. (2022). Differences between expert reported and patient reported burden of disease rankings. Scientific Reports. 12(1). 895–895. 5 indexed citations
4.
Nooten, Floortje van, et al.. (2017). A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises. Value in Health. 20(10). 1403–1410. 2 indexed citations
5.
Agthoven, Michel van, et al.. (2015). A Systematic Review of Literatures on Factors Associated with Educational and Academic Performance in Attention Deficit Hyperactivity Disorder. Creative Education. 6(2). 164–180. 3 indexed citations
7.
Agthoven, Michel van, et al.. (2014). Societal Costs and Qol of Children with Adhd and their Parents: a Comparison to a Reference Group from the General Population. Value in Health. 17(7). A462–A462. 1 indexed citations
8.
Heeg, Bart, Michel van Agthoven, Johan Liwing, et al.. (2014). Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT). Value in Health. 17(7). A617–A618. 2 indexed citations
10.
11.
Levendag, Peter C., et al.. (2005). Cancer in the oropharynx: Cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiotherapy and Oncology. 77(1). 65–72. 17 indexed citations
12.
Doorduijn, Jeanette K., et al.. (2004). Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma.. PubMed. 89(9). 1109–17. 23 indexed citations
13.
Oostenbrink, Jan B., et al.. (2003). Unit Costs of Inpatient Hospital Days. PharmacoEconomics. 21(4). 263–271. 80 indexed citations
14.
Busschbach, Jan J.V., et al.. (2002). Radiotherapie versus CO2-laserbehandeling voor de behandeling van het T1a glottisch larynxcarcinoom. RePub (Erasmus University, Rotterdam). 1 indexed citations
15.
16.
Agthoven, Michel van, Carin A. Uyl‐de Groot, Pieter Sonneveld, et al.. (2002). Cost analysis of CHOP (‐like) chemotherapy regimens for patients with newly diagnosed aggressive non‐Hodgkin's lymphoma. European Journal Of Haematology. 69(4). 213–220. 9 indexed citations
17.
Agthoven, Michel van, B. Martin van Ineveld, Maarten F. de Boer, et al.. (2001). The costs of head and neck oncology. European Journal of Cancer. 37(17). 2204–2211. 57 indexed citations
20.
Agthoven, Michel van, et al.. (2001). Quality of Life of Patients with Refractory Chronic Rhinosinusitis: Effects of Filgrastim Treatment. American Journal of Rhinology. 15(4). 231–237. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026